Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids

Investigative Radiology

Volumn 46, Issue 10, 2011, Pages 639-647

  Kim, Young Sun ^a   Lim, Hyo K ^a   Kim, Jae Hun ^a   Rhim, Hyunchul ^a   Park, Byung Kwan ^a   Keserci, Bilgin ^a,b   Köhler, Max O ^b   Bae, Duk Soo ^a   Kim, Byoung Gie ^a   Lee, Jeong Won ^a   Kim, Tae Joong ^a   Sokka, Shunmugavelu ^b   Lee, Jung Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Ablation therapy; dynamic contrast enhanced magnetic resonance imaging; high intensity focused ultrasound; Uterine fibroid

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE PERFUSION; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERUS MYOMA;

EID: 80052454244     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318220785c     Document Type: Article

References (33)

1. Kim YS, Rhim H, Choi MJ, et al. High-intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol. 2008;9:291-302.
2. ter Haar G. Therapeutic applications of ultrasound. Prog Biophys Mol Biol. 2007;93:111-129.
3. Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-imaging predictors of success. Radiology. 2008;249:187-194.
4. Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189:48-54. (Pubitemid 36886523)
5. Enholm JK, Kohler MO, Quesson B, et al. Improved volumetric MR-HIFU ablation by robust binary feedback control. IEEE Trans Biomed Eng. 2010; 57:103-113.
6. Kohler MO, Mougenot C, Quesson B, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys. 2009;36:3521-3535.
7. Tempany CM, Stewart EA, McDannold N, et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226:897-905. (Pubitemid 36259169)
8. Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007;14: 616-621. (Pubitemid 47369694)
9. Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196:184.e181-184.e186.
10. LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRIguided focused ultrasound treatment: report of 80 patients. Am J Roentgenol. 2010;194:274-280.
11. Okada A, Morita Y, Fukunishi H, et al. Non-invasive magnetic resonanceguided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol. 2009;34:579-583.
12. Mikami K, Murakami T, Okada A, et al. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med. 2008;26:198-205. (Pubitemid 351754723)
13. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1:93-122.
14. Huang J, Holt RG, Cleveland RO, et al. Experimental validation of a tractable numerical model for focused ultrasound heating in flow-through tissue phantoms. J Acoust Soc Am. 2004;116:2451-2458. (Pubitemid 39391647)
15. Li F, Feng R, Zhang Q, et al. Estimation of HIFU induced lesions in vitro: numerical simulation and experiment. Ultrasonics. 2006;44(suppl 1):e337-e340. (Pubitemid 44969900)
16. Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics. 1999;19(spec no):S131-S145.
17. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787-800. (Pubitemid 14094055)
18. Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110: 279-287. (Pubitemid 47356651)
19. Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol. 2004;183:1713-1719. (Pubitemid 44210545)
20. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162-173. (Pubitemid 26266657)
21. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med. 2004;52:420-429. (Pubitemid 39025290)
22. Deoni SC, Rutt BK, Peters TM. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med. 2003;49: 515-526. (Pubitemid 36262820)
23. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223-232. (Pubitemid 29463104)
24. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235: 728-739. (Pubitemid 40695866)
25. Oguchi O, Mori A, Kobayashi Y, et al. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imag-ing prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynaecol (Tokyo 1995). 1995;21:107-117.
26. Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189:721-725. (Pubitemid 23354484)
27. Swe TT, Onitsuka H, Kawamoto K, et al. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Radiat Med. 1992;10:235-242. (Pubitemid 23038225)
28. Padhani AR, Dzik-Jurasz A. Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging. 2004;15:41-57. (Pubitemid 38437544)
29. Liang J, Sammet S, Yang X, et al. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Invest Radiol. 2010;45:233-244.
30. Lowry M, Zelhof B, Liney GP, et al. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol. 2009;44:577-584.
31. Yuh WT, Mayr NA, Jarjoura D, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol. 2009;44:343-350.
32. Li W, Brophy DP, Chen Q, et al. Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization. J Magn Reson Imaging. 2000;12: 1004-1008.
33. Thomassin-Naggara I, Darai E, Nassar-Slaba J, et al. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr. 2007; 31:236-242. (Pubitemid 46573362)